Creatinine Measurement Market Size, Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Russia, Japan, China, India, Australia, South Korea, Mexico, Brazil, Argentina, Saudi Arabia, South Africa, UAE), Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025
Report ID: GMI3804
Creatinine Measurement Market size is expected to grow significantly from 2019 to 2025.
Rising prevalence of renal diseases in developed as well as developing countries will upsurge demand for creatinine measurement market. According to National Chronic Kidney Disease Fact Sheet 2017, 15% of the U.S. adults accounting for around 30 million people are estimated to have chronic kidney disease. Thus, surging demand for serum creatinine determination for renal disease diagnosis will favor business growth. Moreover, increasing prevalence of diabetes worldwide leading to renal diseases should further escalate creatinine measurement industry growth during the forthcoming years.
Additionally, initiatives by various government and non-governmental organizations will serve to be impact rendering factor in the market growth. National Kidney Disease Education Program’s (NKDEP’s) Laboratory Working Group in co-operation with the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) and the European Federation of Clinical Chemistry initiated the Creatinine Standardization Program with an aim to minimize interlaboratory discrepancy in creatinine assay calibration and enhance the accuracy of glomerular filtration rate estimation. These initiatives offer effective diagnosis and treatment for various kidney diseases thereby, improving patient outcomes and fostering industry growth. However, stringent regulatory policies and shifting preference of healthcare professionals towards novel renal dysfunction biomarkers may impede creatinine measurement market growth over the forecast period.
Jaffe’s kinetic method segment accounted for considerable revenue share in 2018 and is estimated to show robust growth over the coming years. Growing prevalence of renal diseases in developed as well as developing countries is the key factor driving segment growth. Increasing demand for kits and reagents used in Jaffe’s kinetic method owing to its widespread availability and cost-effectiveness will surge segment growth over the coming years.
Blood sample segment is anticipated to witness lucrative growth during the forthcoming years. Adoption of kits and reagents based on the analysis of creatinine in blood samples is increasing owing to its benefits such as low risk of contamination as well as greater accuracy in determining creatinine concentration. Such factors will thus spur business size over the analysis period.
Hospitals segment held substantial revenue share in 2018 and is projected to show significant growth over the forecast period. Segment growth is attributed to growing incidence of kidney diseases coupled with surge in number of hospital admissions. Increasing patients preference towards hospitals settings for disease detection and treatment will favor segment growth.
North America creatinine measurement market accounted for momentous revenue in 2018 and will witness similar growth over the analysis timeframe. Rising prevalence of kidney disorders in the region is the major factor driving North America creatinine measurement industry growth. Availability of well-developed healthcare infrastructure coupled with increasing healthcare expenditure will foster regional business growth.
Some of the prominent players operating in creatinine measurement market share include Abbott, Danaher, DIALAB, Diazyme Laboratories, F. Hoffmann-la Roche, Pointe Scientific, Randox Laboratories, Sentinel Diagnostics, Siemens Healthineers and Thermo Fisher Scientific. Companies mainly focus on innovative product launch as well as strategic alliances including partnerships and acquisitions to capitalize on market opportunities and gain more market share.
Creatinine Measurement Market By Product, 2014-2025 (USD Million)
Creatinine Measurement Market By Sample Type, 2014-2025 (USD Million)
Creatinine Measurement Market By Test Type, 2014-2025 (USD Million)
- Jaffe’s kinetic method
- Enzymatic method
Creatinine Measurement Market By End-use, 2014-2025 (USD Million)
- Diagnostic laboratories
The above information is provided for the following regions and countries:
- North America
- Asia Pacific
- South Korea
- Latin America
- Middle East and Africa
- Saudi Arabia
- South Africa
- Abbott Laboratories
- Danaher Corporation
- DIALAB GmbH
- Diazyme Laboratories
- F. Hoffmann-la Roche Ltd
- Pointe Scientific
- Randox Laboratories
- Sentinel Diagnostics
- Siemens Healthineers
- Thermo Fisher Scientific
What Information does this report contain?
Customize this Report
Our Market Research Reports Include:
- Market snapshot
- Market Segmentation
- Value Chain Analysis
- Growth Dynamics
- Potential Market Opportunities
- Regulatory Overview
- Technology Evolution
- Innovation & Sustainability
Why Global Market Insights?Comprehensive Research
- All-inclusive coverage
- In-depth and granular data (ex: information for 8 to 15 countries, with clients open to add to this list, in each report)
- Penetrative insights & latest trends
- Offers holistic understanding of the market
- Unique methodology
- Iterative in nature to eliminate errors
- Detailed methodology, scope, assumptions and data sources available for reference
- Committed to making a positive difference for our clients
- Given the nature of this industry, we are committed to ensure that our clients get maximum return on their investment in our services
- Every purchase comes with an option to obtain additional information:
- up to 10% of the original cost
- 45-minute analyst tele-call to obtain further clarity on the market.
- Global Market Insights, Inc. strictly adheres to PCI-DSS security norms.
- Only PCI-DSS compliant payment methods used for highest level of client data security
Connect with our sales team